Back to Search
Start Over
Omalizumab as single-dose therapy for vernal keratoconjunctivitis.
- Source :
-
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2019 Jan; Vol. 122 (1), pp. 119-120. Date of Electronic Publication: 2018 Sep 20. - Publication Year :
- 2019
- Subjects :
- Conjunctivitis, Allergic immunology
Cyproheptadine analogs & derivatives
Cyproheptadine therapeutic use
Humans
Immunoglobulin E immunology
Keratoconjunctivitis immunology
Male
Middle Aged
Olopatadine Hydrochloride therapeutic use
Anti-Allergic Agents therapeutic use
Conjunctivitis, Allergic drug therapy
Keratoconjunctivitis drug therapy
Omalizumab therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1534-4436
- Volume :
- 122
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
- Publication Type :
- Report
- Accession number :
- 30243989
- Full Text :
- https://doi.org/10.1016/j.anai.2018.09.458